Renal cell carcinoma: ten years of significant advances

被引：3
作者：
Rixe, Olivier [1 ]
Rini, Brian [2 ]
机构：
[1] Univ Cincinnati, Coll Med, Expt Therapeut Program, Cincinnati, OH 45267 USA
[2] Cleveland Clin, Dept Solid Tumor Oncol, Taussig Canc Inst, Cleveland, OH 44195 USA
来源：
TARGETED ONCOLOGY | 2010年 / 5卷 / 02期
关键词：
ANTIBODY;
D O I：
10.1007/s11523-010-0150-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：73 / 74
页数：2
相关论文
共 7 条
[1]   Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer [J].
Faivre, S ;
Delbaldo, C ;
Vera, K ;
Robert, C ;
Lozahic, S ;
Lassau, N ;
Bello, C ;
Deprimo, S ;
Brega, A ;
Massimini, G ;
Armand, JP ;
Scigalla, P ;
Raymond, E .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) :25-35
[2]   Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].
Hodi, F. Stephen ;
O'Day, Steven J. ;
McDermott, David F. ;
Weber, Robert W. ;
Sosman, Jeffrey A. ;
Haanen, John B. ;
Gonzalez, Rene ;
Robert, Caroline ;
Schadendorf, Dirk ;
Hassel, Jessica C. ;
Akerley, Wallace ;
van den Eertwegh, Alfons J. M. ;
Lutzky, Jose ;
Lorigan, Paul ;
Vaubel, Julia M. ;
Linette, Gerald P. ;
Hogg, David ;
Ottensmeier, Christian H. ;
Lebbe, Celeste ;
Peschel, Christian ;
Quirt, Ian ;
Clark, Joseph I. ;
Wolchok, Jedd D. ;
Weber, Jeffrey S. ;
Tian, Jason ;
Yellin, Michael J. ;
Nichol, Geoffrey M. ;
Hoos, Axel ;
Urba, Walter J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723
[3]   Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing [J].
Leary, Rebecca J. ;
Kinde, Isaac ;
Diehl, Frank ;
Schmidt, Kerstin ;
Clouser, Chris ;
Duncan, Cisilya ;
Antipova, Alena ;
Lee, Clarence ;
McKernan, Kevin ;
De la Vega, Francisco M. ;
Kinzler, Kenneth W. ;
Vogelstein, Bert ;
Diaz, Luis A., Jr. ;
Velculescu, Victor E. .
SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (20) :20ra14
[4]   Renal cell carcinoma [J].
Rini, Brian I. ;
Campbell, Steven C. ;
Escudier, Bernard .
LANCET, 2009, 373 (9669) :1119-1132
[5]   Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis [J].
Yang, James C. ;
Hughes, Harybeth ;
Kammula, Udai ;
Royal, Riehard ;
Sherry, Riehard M. ;
Topalian, Suzanne L. ;
Suri, Kimberly B. ;
Levy, Catherine ;
Allen, Tamika ;
Mavroukakis, Sharon ;
Lowy, Israel ;
White, Donald E. ;
Rosenberg, Steven A. .
JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) :825-830
[6]   Immunotherapy for renal cell cancer [J].
Yang, James C. ;
Childs, Richard .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (35) :5576-5583
[7]   A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer [J].
Yang, JC ;
Haworth, L ;
Sherry, RM ;
Hwu, P ;
Schwartzentruber, DJ ;
Topalian, SL ;
Steinberg, SM ;
Chen, HX ;
Rosenberg, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (05) :427-434
1